cannabidiol, CBD, Food and Drug Administration, FDA, regulation, cannabis
After the passage of the 2018 Farm Bill, champions of hemp began to tout opportunities for farmers and businesses involved with the crop. The industry has rallied around one of hemp’s major byproducts, cannabidiol, or CBD. However, the demand for CBD has left the Food and Drug Administration (“FDA”) playing catch-up. This article explains what CBD is, how it is derived, current FDA-approved uses, and a current path forward for the FDA in creating guidance for industry and consumers.
Catt, H. (2020). Going Hemp Wild: Understanding the Challenges and Opportunities for FDA Regulation of CBD in Food Products. Journal of Food Law & Policy, 15(2). Retrieved from https://scholarworks.uark.edu/jflp/vol15/iss2/8